Results 61 to 70 of about 81,528 (247)

Benralizumab for Chronic Spontaneous Urticaria.

open access: yesNew England Journal of Medicine, 2020
Benralizumab for Chronic Spontaneous Urticaria Benralizumab, an anti–interleukin-5-receptor antibody, was evaluated in a 24-week study involving 12 patients with chronic spontaneous urticaria.
J. Bernstein   +5 more
semanticscholar   +1 more source

Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test (mBAT) in a field study

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Basophils are effector cells in type I hypersensitivity reactions. Upon cross‐linking of surface‐bound (allergen‐specific) IgE, basophils release a variety of mediators. Determining the activation of basophils ex vivo with anti‐IgE (a basophil activation test or BAT) can be achieved using flow cytometry.
T. C. Pelgrim   +7 more
wiley   +1 more source

Urticaria and COVID‐19: A review

open access: yesDermatologic Therapy, 2020
The first cases of the coronavirus disease (COVID‐19) appeared in Wuhan, China, in December 2019. COVID‐19 was declared a pandemic in March 2020. Cutaneous manifestations are among the heterogenous clinical features of the disease, and urticaria is one ...
S. Algaadi
semanticscholar   +1 more source

Dupilumab‐Related Adverse Events and Intolerance in Aspirin‐Exacerbated Respiratory Disease Patients

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Lancelot P. Herpin   +8 more
wiley   +1 more source

Cellular Responses to Tartrazine and Sulfanilic Acid Exposure in BEAS‐2B Cells: Viability, Apoptosis, and DNA Damage

open access: yesJournal of Applied Toxicology, EarlyView.
ABSTRACT Tartrazine is a synthetic azo dye widely used in food, pharmaceutical, and cosmetic products, resulting in extensive human exposure, while its toxicity and that of its primary metabolite, sulfanilic acid, remain controversial. Considering the reported association of tartrazine with hypersensitivity and allergic‐like reactions, human bronchial ...
Merve Baysal   +5 more
wiley   +1 more source

Urticaria and infections

open access: yesAllergy, Asthma & Clinical Immunology, 2009
Urticaria is a group of diseases that share a distinct skin reaction pattern. Triggering of urticaria by infections has been discussed for many years but the exact role and pathogenesis of mast cell activation by infectious processes is unclear.
Wedi Bettina   +3 more
doaj   +1 more source

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2017
Chronic spontaneous urticaria (CSU) can be debilitating, difficult to treat, and frustrating for patients and physicians. Real‐world evidence for the burden of CSU is limited.
M. Maurer   +21 more
semanticscholar   +1 more source

Effect of cow's milk protein allergy during infancy on eating behavior at 4 years of age: A cohort study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives This study aimed to investigate the eating behaviors of preschool children who had been exposed to a restricted diet due to an oral food challenge‐confirmed diagnosis of cow's milk protein allergy (CMPA) during early infancy. Methods This prospective cohort study compared the eating behaviors of Brazilian children previously ...
Anne Jardim‐Botelho   +7 more
wiley   +1 more source

Chronic urticaria: new management options

open access: yesWorld Allergy Organization Journal, 2014
Chronic urticaria is defined as episodic or daily hives lasting for at least 6 weeks and impairs quality of life. Two main subtypes include chronic idiopathic (spontaneous) urticaria and inducible (physical) urticaria, but some patients have urticarial ...
Paul A. Greenberger
doaj   +1 more source

Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence

open access: yesJAMA dermatology, 2019
Importance Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) (also known as chronic spontaneous urticaria) in adolescents and adults with persistent hives not controlled with antihistamines.
M. Tharp   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy